A study on pharmacokinetics, pharmacodynamics and safety of lixisenatide in children and adolescents with type 2 diabetes-Reference-Cited by-同舟云学术

A study on pharmacokinetics, pharmacodynamics and safety of lixisenatide in children and adolescents with type 2 diabetes

Published:2022-04-24 Issue:6 Volume:23 Page:641-648
ISSN:1399-543X
Container-title:Pediatric Diabetes
language:en
Short-container-title:Pediatric Diabetes

Author:

Barrientos‐Pérez Margarita¹,Hsia Daniel S.²^ORCID,Sloan Lance³⁴,Nell Haylene⁵,Mungur Ounisha⁶,Hovsepian Lionel⁷,Schmider Wolfgang⁸,Spranger Robert⁸,Yang Na⁹,Niemoeller Elisabeth⁸

Affiliation:

1. Department of Paediatric Endocrinology Angeles Hospital of Puebla Puebla City Mexico

2. Pennington Biomedical Research Center Baton Rouge Louisiana USA

3. Texas Institute for Kidney and Endocrine Disorders Lufkin Texas USA

4. Department of Internal Medicine University of Texas Medical Branch Galveston Texas USA

5. Tiervlei Trial Centre Karl Bremer Hospital Cape Town South Africa

6. CAP Research Quatre Bornes Mauritius

7. Sanofi Paris France

8. Sanofi Frankfurt Germany

9. Sanofi Beijing China

Publisher

Hindawi Limited

Subject

Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pedi.13343

Reference31 articles.

1. Youth-Onset Type 2 Diabetes Consensus Report: Current Status, Challenges, and Priorities

2. Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012

3. Obesity and Type 2 Diabetes in Children: Epidemiology and Treatment

4. Prevalence of obesity among adults and youth: United States, 2015–2016;Hales CM;NCHS Data Brief,2017

5. The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon‐like peptide‐1 receptor agonists in adolescents with overweight or obesity with or without type 2 diabetes multimorbidity—a systematic review and network meta‐analysis;Diabetes, Obesity and Metabolism;2024-07-23

2. The effect of subcutaneous Lixisenatide on weight loss in patients with type 2 Diabetes Mellitus: Systematic review and Meta-Analysis of randomized controlled trials;Diabetes Research and Clinical Practice;2024-04

3. The effects of incretin‐based therapies on weight reduction and metabolic parameters in children with obesity: A systematic review and meta‐analysis;Obesity Reviews;2024-01-10

4. Unmet Needs in the Treatment of Childhood Type 2 Diabetes: A Narrative Review;Advances in Therapy;2023-09-05

5. The Discovery and Development of Glucagon-Like Peptide-1 Receptor Agonists.;Current Medicinal Chemistry;2023-04-16